Newsstand Menu

How to stop cancer cachexia? Start at the top

image of area postrema neurons
Neurons (blue) in a part of the brain called the area postrema, seen here, express a variety of genes, including receptors for the immune system molecule IL-6 (white).
Print Friendly, PDF & Email

Cancer is insidious. Throughout tumor progression, the disease hijacks otherwise healthy biological processes—like the body’s immune response—to grow and spread. When tumors elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause severe brain dysfunction. In about 50%-80% of cancer patients, this leads to a lethal wasting disease called cachexia. “It’s a very severe syndrome,” says Cold Spring Harbor Laboratory (CSHL) Professor Bo Li. He explains:

“Most people with cancer die of cachexia instead of cancer. And once the patient enters this stage, there’s no way to go back because essentially there’s no treatment.”

image of hyperactive neurons
Left: Hyperactive neurons (pink) in the AP before treatment with antibodies (top) and CRISPR (bottom). Right: The AP after treatment. Note the significant reduction in hyperactive neurons.

Now, Li and a team of collaborators from four CSHL labs have found that blocking IL-6 from binding to neurons in a part of the brain called the area postrema (AP) prevents cachexia in mice. As a result, the mice live longer with healthier brain function. Future drugs targeting these neurons could help make cancer cachexia a treatable disease.

In healthy patients, IL-6 plays a crucial role in natural immune response. The molecules circulate throughout the body. When they encounter a possible threat, they alert the brain to coordinate a response. Cancer disrupts this process. Too much IL-6 gets produced, and it begins binding to AP neurons in the brain. “That leads to several consequences,” Li says. “One is animals and humans alike will stop eating. Another is to engage this response that leads to the wasting syndrome.”

The team took a two-pronged approach to keeping elevated IL-6 out of the brain in mice. Their first strategy neutralized IL-6 with custom antibodies. The second used CRISPR to reduce the levels of IL-6 receptors in AP neurons. Remarkably, both tactics produced the same results—the mice started eating again, stopped losing weight, and lived longer.

For Li, the implications were mind-blowing:

“The brain is so powerful in regulating the peripheral system. Simply changing a small number of neurons in the brain has a profound effect on whole-body physiology. I knew there was an interaction between tumors and brain function, but not to this extent.”

Li says his team is now determined to figure out how to translate this discovery to human patients. Their recent collaborations with CSHL Professor Adrian Krainer and former CSHL Professor Z. Josh Huang may bring them one step closer. “If we can use what we’ve learned to prevent or treat cachexia, we can dramatically increase patients’ quality of life,” Li says. “This could one day have a big impact on many people.”

Written by: Nick Wurm, Communications Specialist | | 516-367-5940


Print Friendly, PDF & Email

The Lustgarten Foundation, Thompson Family Foundation, Pershing Square Foundation, CSHL-Northwell Health Affiliation, Northwell Health, Cold Spring Harbor Laboratory Association, National Institutes of Health, Simons Foundation, National Cancer Institute, Cancer Grand Challenges, Mark Foundation for Cancer Research, Osprey Foundation, Fortune Footwear, Key Research and Development Program of Zhejiang Province


Print Friendly, PDF & Email

Sun, Q., et al., “Area postrema neurons mediate interleukin-6 function in cancer cachexia”, Nature Communications, June 1, 2024. DOI: 10.1038/s41467-024-48971-1

Core Facilites

Animal Facility “The Animal Shared Resource houses and cares for the animals essential for scientific research. Our staff perform all aspects of animal husbandry, ensure humane care, and assist researchers with highly technical procedures and protocol design and development.” — Animal Facility Director and Attending Veterinarian Rachel Rubino, DVM

image of the microscopy core facility icon “The Microscopy Core Facility provides training, consultation, experimental design and technical assistance to investigators at CSHL in widefield, spinning disk laser scanning or point laser scanning confocal fluorescence microscopy, and super-resolution microscopy. In addition, the Microscopy Shared Resource provides customized state-of-the-art optical imaging and quantitative image analysis applications to support a wide range of scientific endeavors.” — Director Erika Wee, Ph.D.

Animal Tissue Imaging “The Tissue Imaging Shared Resource provides a spectrum of on-demand and researcher-tailored histopathological services, including tissue sampling, processing, embedding, and sectioning, as well as H&E, special, and immunohistochemistry staining. We not only support laser-capture microdissection and whole-slide scanning, but also offer histopathology consultation and instrument training.” — Manager Qing Gao, Ph.D., M.D.

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup

Principal Investigator

Bo Li

Bo Li

Robert Lourie Professor of Neuroscience
Ph.D., The University of British Columbia, 2003